SCHEMBL7255774

SCHEMBL7255774

O=C(CCN1CCOCC1)c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 1.00
MAPT P10636 7/20 1.00
KMT2A Q03164 6/20 1.00
LMNA P02545 3/20 0.71
MPI P34949 1/20 0.71
HTR1A P08908 2/20 0.63
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
KCNH2 Q12809 1/20 0.63
CD274 Q9NZQ7 1/20 0.63
HTT P42858 2/20 0.62
TP53 P04637 1/20 0.62
ALDH3A1 P30838 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
THRB P10828 2/20 0.60
THRA P10827 1/20 0.60
SOD1 P00441 1/20 0.59
HPGD P15428 1/20 0.58
TSHR P16473 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11493992 0.96 ALDH1A1 (0.91) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL9512833 0.92 ALDH1A1 (0.84) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL12123789 0.84 ALDH1A1 (0.97) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL12123826 0.84 ALDH1A1 (0.73) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL12123771 0.84 ALDH1A1 (0.73) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL12123790 0.84 ALDH1A1 (0.73) ALDH1A1MAPTKMT2ALMNAMPI
Hydrochloric Acid SCHEMBL5954525 0.84 ALDH1A1 (0.72) ALDH1A1MAPTKMT2ALMNAHTR1A
SCHEMBL321369 0.84 ALDH1A1 (1.00) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL17033397 0.84 ALDH1A1 (0.72) ALDH1A1MAPTKMT2ALMNAHTR1A
SCHEMBL14384878 0.84 ALDH1A1 (0.72) ALDH1A1MAPTKMT2ALMNAMPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705501-A ADMINISTERING TO INHIBIT FORMATION OF ABNORMAL PHOSPHORYLATED PAIRED HELICAL FILAMENT EPITOPES MOLECULAR GERIATRICS CORPORATION (US) 1998-01-06 US claimed
US-20150290200-A1 INTRACELLULAR KINASE INHIBITORS PHARMACYCLICS INC (US) 2015-10-15 US disclosed
US-20150290200-A1 INTRACELLULAR KINASE INHIBITORS PHARMACYCLICS INC (US) 2015-10-15 US disclosed
EP-2865381-A1 ITK inhibitors for treating blood cell malignancies Pharmacyclics, Inc. (US) 2015-04-29 EP disclosed
US-20140080833-A1 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2014-03-20 US disclosed
US-20140080833-A1 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2014-03-20 US disclosed
US-20110281850-A1 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2011-11-17 US disclosed
US-20110281850-A1 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2011-11-17 US disclosed
US-20070293499-A1 Intracellular Kinase Inhibitors MANNKIND CORPORATION (US) 2007-12-20 US disclosed
US-20070293499-A1 Intracellular Kinase Inhibitors MANNKIND CORPORATION (US) 2007-12-20 US disclosed
WO-2007136790-A2 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2007-11-29 WO disclosed
WO-2003104216-A1 UROTENSIN II RECEPTOR MODULATORS ACADIA PHARMACEUTICALS INC. (US) 2003-12-18 WO disclosed
US-6228878-B1 ADMINISTERING INDOLIN-5-ONE DERIVATIVES; INHIBITING FORMATION OF ABNORMALLY PHOSPHORYLATED PAIRED HELICAL FILAMENT EPITOPES MOLECULAR GERIATRICS CORPORATION 2001-05-08 US disclosed
US-5968936-A ADMINISTERING SUBSTITUTED 4,5,6,7-TETRAHYDRO-5-MORPHOLINOMETHYL-4-OXOINDOLES MOLECUALR GERIATRICS CORPORATION (US) 1999-10-19 US disclosed
US-5705501-A ADMINISTERING TO INHIBIT FORMATION OF ABNORMAL PHOSPHORYLATED PAIRED HELICAL FILAMENT EPITOPES MOLECULAR GERIATRICS CORPORATION (US) 1998-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293499-A1 Intracellular Kinase Inhibitors PI4KB, BTK, LTK ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885
US-20150290200-A1 INTRACELLULAR KINASE INHIBITORS PI4KB, BTK, LTK ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885
US-20110281850-A1 INTRACELLULAR KINASE INHIBITORS PI4KB, BTK, LTK ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885
US-20140080833-A1 INTRACELLULAR KINASE INHIBITORS PI4KB, BTK, LTK ALDH1A1 4370/4885MAPT 3284/4885KMT2A 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.